High Tech Pharmaceuticals Co., Ltd. (106190)
Market Open
11 Aug, 05:43
KRX SM KRX SM Primary ₩
11,570. 00
-310
-2.6094%
₩
168.1B Market Cap
- P/E Ratio
266.67% Div Yield
7,251 Volume
- Eps
₩ 11,880
Previous Close Want to track 106190 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
106190 trading today lower at ₩11,570, a decrease of -2.6094% from yesterday's close, completing a monthly decrease of -6.5428% or -₩810. Over the past 12 months, 106190 stock lost -3.8238%.
106190 pays dividends to its shareholders, with the most recent payment made on Jan 03, 2025.
High Tech Pharmaceuticals Co., Ltd. has completed 1 stock splits, with the recent split occurring on Dec 27, 2023.
The company's stock is traded on one exchange.
High Tech Pharmaceuticals Co., Ltd. (106190) FAQ
What is the stock price today?
The current price is ₩11,570.00.
On which exchange is it traded?
High Tech Pharmaceuticals Co., Ltd. is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 106190.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 266.67%.
What is its market cap?
As of today, the market cap is 168.1B.
Has High Tech Pharmaceuticals Co., Ltd. ever had a stock split?
High Tech Pharmaceuticals Co., Ltd. had 1 splits and the recent split was on Dec 27, 2023.
High Tech Pharmaceuticals Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | KRX SM Exchange | - ISIN |
| South Korea Country | - Employees | - Last Dividend | 27 Dec 2023 Last Split | - IPO Date |
Overview
High Tech Pharm Co., Ltd., established in 1998 and headquartered in Daeso-Myeon, South Korea, is at the forefront of the pharmaceutical industry, focusing on the research, development, manufacture, and global distribution of injectable carbapenem antibiotics. These antibiotics are pivotal in combating gram-negative bacterial infections, which are known for their resistance to traditional antibiotics. The company has dedicated itself to providing advanced medical solutions through its range of sterile and aseptic products, ensuring high-quality and effective treatments for patients worldwide.
Products and Services
- Sterile Imipenem: An antibiotic used for the treatment of serious infections caused by susceptible strains of bacteria. It works by inhibiting cell wall synthesis, leading to bacterial cell death.
- Sterile Sodium Silicate: Primarily used as an adjuvant in pharmaceutical formulations and as a buffering agent to maintain pH levels essential for the stability of certain drugs.
- Sterile Imipenem-Cilastatin (1:1): Combines imipenem with cilastatin to prevent the inactivation of imipenem by renal enzymes, enhancing its effectiveness against bacterial infections.
- Aseptic Meropenem: A broad-spectrum carbapenem antibiotic showcasing effectiveness against a wide range of bacterial infections, including those resistant to other antibiotics.
- Sterile Paniepenem for Injection: This is used to treat complex infections caused by susceptible bacteria, leveraging its stability and potency to ensure successful outcomes.
- Oral Paropenem: A unique formulation offering the benefits of carbapenem antibiotics in an oral form, providing an alternative to injection-based treatments.
- Sterile Erthapenem: Ideal for the treatment of moderate to severe infections by multidrug-resistant bacteria, ensuring a broad spectrum of antibacterial activity.
- Aseptic Doripenem: Known for its extended spectrum of activity, it is used in treating more complex bacterial infections, including those caused by Pseudomonas aeruginosa.
- Aseptic Viapenem for Injection: A newer addition, offering a potent solution against a variety of bacterial infections, highlighting the company's commitment to innovation and development in antibiotic therapy.
Contact Information
Address: 12, Cheomdansaneop 6-ro
Phone: 82 4 3880 0011
Website: https://www.htpharm.com
